α2A‐AR antagonism by BRL‐44408 maleate attenuates acute lung injury in rats with downregulation of ERK1/2, p38MAPK, and p65 pathway

Acute respiratory distress syndrome (ARDS), characterized by acute hypoxic respiratory dysfunction or failure, is a manifestation of multiple organ failure in the lung, and the most common risk factor is sepsis. We previously showed that blocking α2‐adrenoceptor (α2‐AR) could attenuate lung injury i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 2020-10, Vol.235 (10), p.6905-6914
Hauptverfasser: Cong, Zhukai, Li, Dan, Tao, Yifan, Lv, Xiangpeng, Zhu, Xi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6914
container_issue 10
container_start_page 6905
container_title Journal of cellular physiology
container_volume 235
creator Cong, Zhukai
Li, Dan
Tao, Yifan
Lv, Xiangpeng
Zhu, Xi
description Acute respiratory distress syndrome (ARDS), characterized by acute hypoxic respiratory dysfunction or failure, is a manifestation of multiple organ failure in the lung, and the most common risk factor is sepsis. We previously showed that blocking α2‐adrenoceptor (α2‐AR) could attenuate lung injury induced by endotoxin in rats. α2A‐adrenoceptor (α2A‐AR), a subtype of α2‐AR plays a key role in inflammatory diseases, but the mechanism remains unknown. Here, we explored the effect of BRL‐44408 maleate (BRL), a specific α2A‐AR antagonist, on cecal ligation puncture (CLP)‐induced ARDS in rats and the underlying mechanism. Preadministration of BRL‐44408 maleate significantly alleviated CLP‐induced histological injury, macrophage infiltration, inflammatory response, and wet/dry ratio in lung tissue. However, there was no statistical difference in survival rate between the CLP and CLP+BRL groups. Extracellular regulated protein kinase (ERK1/2), p38MAPK, and p65 were activated in the CLP group, and BRL‐44408 maleate inhibited the activation of these signal molecules, c‐Jun N‐terminal kinase (JNK) and protein kinase A (PKA) showed no changes in activation between these two groups. BRL‐44408 maleate decreased lipopolysaccharide (LPS)‐induced expression of cytokines in NR8383 rat alveolar macrophages and reduced phosphorylation of ERK1/2, p38MAPK, and p65. JNK and PKA were not influenced by LPS. Together, these findings suggest that antagonism of α2A‐AR improves CLP‐induced acute lung injury and involves the downregulation of ERK1/2, p38MAPK, and p65 pathway independent of the activation of JNK and PKA. ARDS animal models were induced by cecal ligation puncture with an intraperitoneal injection of BRL‐44408 maleate after 5 hours, and sacrificed after 6 hours or 24 hours. NR8383 cell line was incubated with BRL‐44408 maleate for 30 min and then treated with or without LPS (10 ng/mL) for 30 min or 12 hours.
doi_str_mv 10.1002/jcp.29586
format Article
fullrecord <record><control><sourceid>proquest_wiley</sourceid><recordid>TN_cdi_proquest_journals_2430273307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2430273307</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1716-46f76bbf1babac18d9b012ec58a933f234e120fd8b99d50082943d96b1f999513</originalsourceid><addsrcrecordid>eNotUEtOwzAUtBBIlMKCG1hi27T-5eNlqPi2iKqCtWUnTpsodULiKMqOJUuuwkU4BCfBtKxmNG_0RjMAXGI0xQiRWZHUU8L9KDgCI4x46LHAJ8dg5G7Y4z7Dp-CsbQuEEOeUjsDH9xeJf94_4zWUxspNZfJ2B9UAr9dLJzPGUAR3stTSaiit1aZzrIUy6ZxQdmYDc1N0zeAANtK2sM_tFqZVbxq96Upp88rAKoM36wWekQmsafQUrxYTF5fCOvBhLe22l8M5OMlk2eqLfxyD19ubl_m9t3y-e5jHS6_GIQ5cnSwMlMqwkkomOEq5QpjoxI-k65MRyjQmKEsjxXnqIxQRzmjKA4UzzrmP6RhcHf7WTfXW6daKouoa4yIFYRSRkFIUOtfs4OrzUg-ibvKdbAaBkfhbWbiVxX5l8Thf7Qn9Bbmkcds</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2430273307</pqid></control><display><type>article</type><title>α2A‐AR antagonism by BRL‐44408 maleate attenuates acute lung injury in rats with downregulation of ERK1/2, p38MAPK, and p65 pathway</title><source>Access via Wiley Online Library</source><creator>Cong, Zhukai ; Li, Dan ; Tao, Yifan ; Lv, Xiangpeng ; Zhu, Xi</creator><creatorcontrib>Cong, Zhukai ; Li, Dan ; Tao, Yifan ; Lv, Xiangpeng ; Zhu, Xi</creatorcontrib><description>Acute respiratory distress syndrome (ARDS), characterized by acute hypoxic respiratory dysfunction or failure, is a manifestation of multiple organ failure in the lung, and the most common risk factor is sepsis. We previously showed that blocking α2‐adrenoceptor (α2‐AR) could attenuate lung injury induced by endotoxin in rats. α2A‐adrenoceptor (α2A‐AR), a subtype of α2‐AR plays a key role in inflammatory diseases, but the mechanism remains unknown. Here, we explored the effect of BRL‐44408 maleate (BRL), a specific α2A‐AR antagonist, on cecal ligation puncture (CLP)‐induced ARDS in rats and the underlying mechanism. Preadministration of BRL‐44408 maleate significantly alleviated CLP‐induced histological injury, macrophage infiltration, inflammatory response, and wet/dry ratio in lung tissue. However, there was no statistical difference in survival rate between the CLP and CLP+BRL groups. Extracellular regulated protein kinase (ERK1/2), p38MAPK, and p65 were activated in the CLP group, and BRL‐44408 maleate inhibited the activation of these signal molecules, c‐Jun N‐terminal kinase (JNK) and protein kinase A (PKA) showed no changes in activation between these two groups. BRL‐44408 maleate decreased lipopolysaccharide (LPS)‐induced expression of cytokines in NR8383 rat alveolar macrophages and reduced phosphorylation of ERK1/2, p38MAPK, and p65. JNK and PKA were not influenced by LPS. Together, these findings suggest that antagonism of α2A‐AR improves CLP‐induced acute lung injury and involves the downregulation of ERK1/2, p38MAPK, and p65 pathway independent of the activation of JNK and PKA. ARDS animal models were induced by cecal ligation puncture with an intraperitoneal injection of BRL‐44408 maleate after 5 hours, and sacrificed after 6 hours or 24 hours. NR8383 cell line was incubated with BRL‐44408 maleate for 30 min and then treated with or without LPS (10 ng/mL) for 30 min or 12 hours.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.29586</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc</publisher><subject>Activation ; acute respiratory distress syndrome ; Adrenergic receptors ; Alveoli ; BRL‐44408 maleate ; Cecum ; Cytokines ; Endotoxins ; Extracellular signal-regulated kinase ; Hypoxia ; Inflammatory diseases ; Inflammatory response ; Injuries ; JNK protein ; Kinases ; Lipopolysaccharides ; Lungs ; Macrophages ; MAPK and NF‐κB ; Phosphorylation ; Protein kinase A ; Proteins ; Respiratory distress syndrome ; Risk analysis ; Risk factors ; Sepsis ; Survival ; α2A‐AR</subject><ispartof>Journal of cellular physiology, 2020-10, Vol.235 (10), p.6905-6914</ispartof><rights>2020 Wiley Periodicals, Inc.</rights><rights>2020 Wiley Periodicals LLC</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-7026-1765</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcp.29586$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcp.29586$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27926,27927,45576,45577</link.rule.ids></links><search><creatorcontrib>Cong, Zhukai</creatorcontrib><creatorcontrib>Li, Dan</creatorcontrib><creatorcontrib>Tao, Yifan</creatorcontrib><creatorcontrib>Lv, Xiangpeng</creatorcontrib><creatorcontrib>Zhu, Xi</creatorcontrib><title>α2A‐AR antagonism by BRL‐44408 maleate attenuates acute lung injury in rats with downregulation of ERK1/2, p38MAPK, and p65 pathway</title><title>Journal of cellular physiology</title><description>Acute respiratory distress syndrome (ARDS), characterized by acute hypoxic respiratory dysfunction or failure, is a manifestation of multiple organ failure in the lung, and the most common risk factor is sepsis. We previously showed that blocking α2‐adrenoceptor (α2‐AR) could attenuate lung injury induced by endotoxin in rats. α2A‐adrenoceptor (α2A‐AR), a subtype of α2‐AR plays a key role in inflammatory diseases, but the mechanism remains unknown. Here, we explored the effect of BRL‐44408 maleate (BRL), a specific α2A‐AR antagonist, on cecal ligation puncture (CLP)‐induced ARDS in rats and the underlying mechanism. Preadministration of BRL‐44408 maleate significantly alleviated CLP‐induced histological injury, macrophage infiltration, inflammatory response, and wet/dry ratio in lung tissue. However, there was no statistical difference in survival rate between the CLP and CLP+BRL groups. Extracellular regulated protein kinase (ERK1/2), p38MAPK, and p65 were activated in the CLP group, and BRL‐44408 maleate inhibited the activation of these signal molecules, c‐Jun N‐terminal kinase (JNK) and protein kinase A (PKA) showed no changes in activation between these two groups. BRL‐44408 maleate decreased lipopolysaccharide (LPS)‐induced expression of cytokines in NR8383 rat alveolar macrophages and reduced phosphorylation of ERK1/2, p38MAPK, and p65. JNK and PKA were not influenced by LPS. Together, these findings suggest that antagonism of α2A‐AR improves CLP‐induced acute lung injury and involves the downregulation of ERK1/2, p38MAPK, and p65 pathway independent of the activation of JNK and PKA. ARDS animal models were induced by cecal ligation puncture with an intraperitoneal injection of BRL‐44408 maleate after 5 hours, and sacrificed after 6 hours or 24 hours. NR8383 cell line was incubated with BRL‐44408 maleate for 30 min and then treated with or without LPS (10 ng/mL) for 30 min or 12 hours.</description><subject>Activation</subject><subject>acute respiratory distress syndrome</subject><subject>Adrenergic receptors</subject><subject>Alveoli</subject><subject>BRL‐44408 maleate</subject><subject>Cecum</subject><subject>Cytokines</subject><subject>Endotoxins</subject><subject>Extracellular signal-regulated kinase</subject><subject>Hypoxia</subject><subject>Inflammatory diseases</subject><subject>Inflammatory response</subject><subject>Injuries</subject><subject>JNK protein</subject><subject>Kinases</subject><subject>Lipopolysaccharides</subject><subject>Lungs</subject><subject>Macrophages</subject><subject>MAPK and NF‐κB</subject><subject>Phosphorylation</subject><subject>Protein kinase A</subject><subject>Proteins</subject><subject>Respiratory distress syndrome</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Sepsis</subject><subject>Survival</subject><subject>α2A‐AR</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNotUEtOwzAUtBBIlMKCG1hi27T-5eNlqPi2iKqCtWUnTpsodULiKMqOJUuuwkU4BCfBtKxmNG_0RjMAXGI0xQiRWZHUU8L9KDgCI4x46LHAJ8dg5G7Y4z7Dp-CsbQuEEOeUjsDH9xeJf94_4zWUxspNZfJ2B9UAr9dLJzPGUAR3stTSaiit1aZzrIUy6ZxQdmYDc1N0zeAANtK2sM_tFqZVbxq96Upp88rAKoM36wWekQmsafQUrxYTF5fCOvBhLe22l8M5OMlk2eqLfxyD19ubl_m9t3y-e5jHS6_GIQ5cnSwMlMqwkkomOEq5QpjoxI-k65MRyjQmKEsjxXnqIxQRzmjKA4UzzrmP6RhcHf7WTfXW6daKouoa4yIFYRSRkFIUOtfs4OrzUg-ibvKdbAaBkfhbWbiVxX5l8Thf7Qn9Bbmkcds</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Cong, Zhukai</creator><creator>Li, Dan</creator><creator>Tao, Yifan</creator><creator>Lv, Xiangpeng</creator><creator>Zhu, Xi</creator><general>Wiley Subscription Services, Inc</general><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0001-7026-1765</orcidid></search><sort><creationdate>202010</creationdate><title>α2A‐AR antagonism by BRL‐44408 maleate attenuates acute lung injury in rats with downregulation of ERK1/2, p38MAPK, and p65 pathway</title><author>Cong, Zhukai ; Li, Dan ; Tao, Yifan ; Lv, Xiangpeng ; Zhu, Xi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1716-46f76bbf1babac18d9b012ec58a933f234e120fd8b99d50082943d96b1f999513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Activation</topic><topic>acute respiratory distress syndrome</topic><topic>Adrenergic receptors</topic><topic>Alveoli</topic><topic>BRL‐44408 maleate</topic><topic>Cecum</topic><topic>Cytokines</topic><topic>Endotoxins</topic><topic>Extracellular signal-regulated kinase</topic><topic>Hypoxia</topic><topic>Inflammatory diseases</topic><topic>Inflammatory response</topic><topic>Injuries</topic><topic>JNK protein</topic><topic>Kinases</topic><topic>Lipopolysaccharides</topic><topic>Lungs</topic><topic>Macrophages</topic><topic>MAPK and NF‐κB</topic><topic>Phosphorylation</topic><topic>Protein kinase A</topic><topic>Proteins</topic><topic>Respiratory distress syndrome</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Sepsis</topic><topic>Survival</topic><topic>α2A‐AR</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cong, Zhukai</creatorcontrib><creatorcontrib>Li, Dan</creatorcontrib><creatorcontrib>Tao, Yifan</creatorcontrib><creatorcontrib>Lv, Xiangpeng</creatorcontrib><creatorcontrib>Zhu, Xi</creatorcontrib><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cong, Zhukai</au><au>Li, Dan</au><au>Tao, Yifan</au><au>Lv, Xiangpeng</au><au>Zhu, Xi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>α2A‐AR antagonism by BRL‐44408 maleate attenuates acute lung injury in rats with downregulation of ERK1/2, p38MAPK, and p65 pathway</atitle><jtitle>Journal of cellular physiology</jtitle><date>2020-10</date><risdate>2020</risdate><volume>235</volume><issue>10</issue><spage>6905</spage><epage>6914</epage><pages>6905-6914</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><abstract>Acute respiratory distress syndrome (ARDS), characterized by acute hypoxic respiratory dysfunction or failure, is a manifestation of multiple organ failure in the lung, and the most common risk factor is sepsis. We previously showed that blocking α2‐adrenoceptor (α2‐AR) could attenuate lung injury induced by endotoxin in rats. α2A‐adrenoceptor (α2A‐AR), a subtype of α2‐AR plays a key role in inflammatory diseases, but the mechanism remains unknown. Here, we explored the effect of BRL‐44408 maleate (BRL), a specific α2A‐AR antagonist, on cecal ligation puncture (CLP)‐induced ARDS in rats and the underlying mechanism. Preadministration of BRL‐44408 maleate significantly alleviated CLP‐induced histological injury, macrophage infiltration, inflammatory response, and wet/dry ratio in lung tissue. However, there was no statistical difference in survival rate between the CLP and CLP+BRL groups. Extracellular regulated protein kinase (ERK1/2), p38MAPK, and p65 were activated in the CLP group, and BRL‐44408 maleate inhibited the activation of these signal molecules, c‐Jun N‐terminal kinase (JNK) and protein kinase A (PKA) showed no changes in activation between these two groups. BRL‐44408 maleate decreased lipopolysaccharide (LPS)‐induced expression of cytokines in NR8383 rat alveolar macrophages and reduced phosphorylation of ERK1/2, p38MAPK, and p65. JNK and PKA were not influenced by LPS. Together, these findings suggest that antagonism of α2A‐AR improves CLP‐induced acute lung injury and involves the downregulation of ERK1/2, p38MAPK, and p65 pathway independent of the activation of JNK and PKA. ARDS animal models were induced by cecal ligation puncture with an intraperitoneal injection of BRL‐44408 maleate after 5 hours, and sacrificed after 6 hours or 24 hours. NR8383 cell line was incubated with BRL‐44408 maleate for 30 min and then treated with or without LPS (10 ng/mL) for 30 min or 12 hours.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/jcp.29586</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7026-1765</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0021-9541
ispartof Journal of cellular physiology, 2020-10, Vol.235 (10), p.6905-6914
issn 0021-9541
1097-4652
language eng
recordid cdi_proquest_journals_2430273307
source Access via Wiley Online Library
subjects Activation
acute respiratory distress syndrome
Adrenergic receptors
Alveoli
BRL‐44408 maleate
Cecum
Cytokines
Endotoxins
Extracellular signal-regulated kinase
Hypoxia
Inflammatory diseases
Inflammatory response
Injuries
JNK protein
Kinases
Lipopolysaccharides
Lungs
Macrophages
MAPK and NF‐κB
Phosphorylation
Protein kinase A
Proteins
Respiratory distress syndrome
Risk analysis
Risk factors
Sepsis
Survival
α2A‐AR
title α2A‐AR antagonism by BRL‐44408 maleate attenuates acute lung injury in rats with downregulation of ERK1/2, p38MAPK, and p65 pathway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T17%3A33%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B12A%E2%80%90AR%20antagonism%20by%20BRL%E2%80%9044408%20maleate%20attenuates%20acute%20lung%20injury%20in%20rats%20with%20downregulation%20of%20ERK1/2,%20p38MAPK,%20and%20p65%20pathway&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Cong,%20Zhukai&rft.date=2020-10&rft.volume=235&rft.issue=10&rft.spage=6905&rft.epage=6914&rft.pages=6905-6914&rft.issn=0021-9541&rft.eissn=1097-4652&rft_id=info:doi/10.1002/jcp.29586&rft_dat=%3Cproquest_wiley%3E2430273307%3C/proquest_wiley%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2430273307&rft_id=info:pmid/&rfr_iscdi=true